Linical Co

Linical Co Total Shareholder Payout

The Total Shareholder Payout of Linical Co (2183.T) as of Nov 7, 2026 is 360.95 M JPY. In the previous year, Total Shareholder Payout was 338.48 M JPY — a change of 6.64% (higher).

Total Shareholder Payout

360.95 MJPY

YoY

6.64%

Last updated:

Total Shareholder Payout of Linical Co is 2026 360.95 M JPY. Total Shareholder Payout of Linical Co was 2025 338.48 M JPY. It decreases by 6.64% higher compared to the previous year.

The Linical Co Total Shareholder Payout history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Shareholder Payout
Date
Total Shareholder Payout
Jan 1, 2019
504.94 M JPY
Jan 1, 2020
271.01 M JPY
Jan 1, 2021
316.38 M JPY
Jan 1, 2022
316.04 M JPY
Jan 1, 2023
316.04 M JPY
Jan 1, 2024
315.77 M JPY
Jan 1, 2025
338.48 M JPY
Jan 1, 2026
360.95 M JPY
The Linical Co Total Shareholder Payout history
YEARTotal Shareholder PayoutYoY
360.95 MJPY+6.64%
338.48 MJPY+7.19%
315.77 MJPY-0.09%
316.04 MJPY-0.00%
316.04 MJPY-0.11%
316.38 MJPY+16.74%
271.01 MJPY-46.33%
504.94 MJPY+80.38%
279.93 MJPY-2.97%
288.49 MJPY+81.03%
159.36 MJPY-0.05%
159.44 MJPY-15.18%
187.97 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Total Shareholder Payout of Linical Co is 360.95 M JPY in 2026.

Total Shareholder Payout of Linical Co changed from 338.48 M JPY to 360.95 M JPY, representing a 6.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Shareholder Payout Linical Co since 2006 – with annual values, charts, and detailed analysis.

Total shareholder payout combines dividends paid and share buybacks, representing the total cash returned to shareholders during the period.

Total Shareholder Payout's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Shareholder Payout's Linical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Linical Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Linical Co